LncRNA SLC16A1-AS1 is Upregulated in Glioblastoma and Promotes Cancer Cell Proliferation by Regulating miR-149 Methylation

References

• Alexander BM, Cloughesy TF. Adult Glioblastoma. J Clin Oncol. 2017;35(21):2402–2409. doi:10.1200/JCO.2017.73.011928640706
   PubMed Web of Science ®Google Scholar
• Chen X, Xu Z, Zeng S, et al. SIRT5 downregulation is associated with poor prognosis in glioblastoma. Cancer Biomark. 2019;24(4):449–459. doi:10.3233/CBM-18219730909186
   PubMed Web of Science ®Google Scholar
• Chen X, Yan Y, Zhou J, et al. Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients. Ann Transl Med. 2019;7(20):541. doi:10.21037/atm.2019.09.12631807523
   PubMed Web of Science ®Google Scholar
• Wu G, Yan Y, Zhou Y, et al. Expression and clinical significance of CPS1 in glioblastoma multiforme. Curr Res Transl Med. 2019;67(4):123–128. doi:10.1016/j.retram.2019.08.00331492588
   PubMed Web of Science ®Google Scholar
• Soderberg-Naucler C, Rahbar A, Stragliotto G. Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med. 2013;369(10):985–986. doi:10.1056/NEJMc130214524004141
   PubMed Web of Science ®Google Scholar
• Brown TJ, Brennan MC, Li M, et al. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol. 2016;2(11):1460–1469. doi:10.1001/jamaoncol.2016.137327310651
   PubMed Web of Science ®Google Scholar
• Alifieris C, Trafalis DT. Glioblastoma multiforme: pathogenesis and treatment. Pharmacol Ther. 2015;152:63–82.25944528
   PubMed Web of Science ®Google Scholar
• Dai S, Yan Y, Xu Z, et al. SCD1 confers temozolomide resistance to human glioma cells via the Akt/GSK3beta/beta-Catenin signaling axis. Front Pharmacol. 2017;8:960. doi:10.3389/fphar.2017.0096029354058
   PubMed Web of Science ®Google Scholar
• Yan Y, Li Z, Zeng S, Wang X, Gong Z, Xu Z. FGFR2-mediated phosphorylation of PTEN at tyrosine 240 contributes to the radioresistance of glioma. J Cell Commun Signal. 2019;13(3):279–280. doi:10.1007/s12079-019-00518-631025173
   PubMed Web of Science ®Google Scholar
• Taylor MA, Das BC, Ray SK. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma. Apoptosis. 2018;23(11–12):563–575. doi:10.1007/s10495-018-1480-930171377
   PubMed Web of Science ®Google Scholar
• Sanna V, Pala N, Sechi M. Targeted therapy using nanotechnology: focus on cancer. Int J Nanomed. 2014;9:467–483. doi:10.2147/IJN.S36654
   PubMed Web of Science ®Google Scholar
• Touat M, Idbaih A, Sanson M, Ligon KL. Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol. 2017;28(7):1457–1472.28863449
   PubMed Web of Science ®Google Scholar
• Li X, Wu C, Chen N, et al. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7(22):33440–33450. doi:10.18632/oncotarget.796126967052
   PubMedGoogle Scholar
• Ma Y, Cheng Z, Liu J, et al. Inhibition of farnesyltransferase potentiates NOTCH-targeted therapy against glioblastoma stem cells. Stem Cell Rep. 2017;9(6):1948–1960. doi:10.1016/j.stemcr.2017.10.028
   PubMed Web of Science ®Google Scholar
• Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719. doi:10.4161/rna.2048122664915
   PubMed Web of Science ®Google Scholar
• Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015;15:38. doi:10.1186/s12935-015-0185-125960691
   PubMed Web of Science ®Google Scholar
• Yan Y, Chen X, Wang X, et al. The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer. J Exp Clin Cancer Res. 2019;38(1):171. doi:10.1186/s13046-019-1172-531014370
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391–407. doi:10.1158/2159-8290.CD-11-020922096659
   PubMed Web of Science ®Google Scholar
• Yan Y, Xu Z, Chen X, et al. Novel function of lncRNA ADAMTS9-AS2 in promoting temozolomide resistance in glioblastoma via upregulating the FUS/MDM2 ubiquitination axis. Front Cell Dev Biol. 2019;7:217. doi:10.3389/fcell.2019.0021731632968
   PubMed Web of Science ®Google Scholar
• Peng Z, Liu C, Wu M. New insights into long noncoding RNAs and their roles in glioma. Mol Cancer. 2018;17.29386021
   PubMed Web of Science ®Google Scholar
• Dang Y, Wei X, Xue L, Wen F, Gu J, Zheng H. Long non-coding RNA in glioma: target miRNA and signaling pathways. Clin Lab. 2018;64:887–894. doi:10.7754/Clin.Lab.2018.18010729945317
   PubMed Web of Science ®Google Scholar
• Li J, Liang R, Song C, Xiang Y, Liu Y. Prognostic and clinicopathological significance of long non-coding RNA in glioma. Neurosurg Rev. 2018;43:43. doi:10.1007/s10143-018-0965-x
   Web of Science ®Google Scholar
• Liu HY, Lu SR, Guo ZH, et al. lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer. J Investig Med. 2020;68(1):52–59. doi:10.1136/jim-2019-001080
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx24728407145
   PubMed Web of Science ®Google Scholar
• Sanchez-Gonzalez I, Bobien A, Molnar C, et al. miR-149 suppresses breast cancer metastasis by blocking paracrine interactions with macrophages. Cancer Res. 2020;80(6):1330–1341. doi:10.1158/0008-5472.CAN-19-193431911555
   PubMed Web of Science ®Google Scholar
• Pan SJ, Zhan SK, Pei BG, Sun QF, Bian LG, Sun BM. MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling. Int J Immunopathol Pharmacol. 2012;25(4):871–881. doi:10.1177/03946320120250040523298478
   PubMed Web of Science ®Google Scholar
• She X, Yu Z, Cui Y, et al. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma. Oncol Rep. 2014;32(3):957–964. doi:10.3892/or.2014.331825017996
   PubMed Web of Science ®Google Scholar
• Xue L, Wang Y, Yue S, Zhang J. Low MiR-149 expression is associated with unfavorable prognosis and enhanced Akt/mTOR signaling in glioma. Int J Clin Exp Pathol. 2015;8:11178–11184.26617839
   PubMed Web of Science ®Google Scholar
• Ghasemi A, Fallah S, Ansari M. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme. Biochem Cell Biol. 2016;94:1–8. doi:10.1139/bcb-2015-006426352678
   PubMed Web of Science ®Google Scholar
• Kiss T, Giles CB, Tarantini S, et al. Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects. Geroscience. 2019;41(4):419–439. doi:10.1007/s11357-019-00095-x31463647
   PubMed Web of Science ®Google Scholar
• Braun DJ, Bachstetter AD, Sudduth TL, Wilcock DM, Watterson DM, Van Eldik LJ. Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia. Geroscience. 2019;41(5):671–679. doi:10.1007/s11357-019-00072-431104189
   PubMed Web of Science ®Google Scholar
• Matyi S, Jackson J, Garrett K, Deepa SS, Unnikrishnan A. The effect of different levels of dietary restriction on glucose homeostasis and metabolic memory. Geroscience. 2018;40(2):139–149. doi:10.1007/s11357-018-0011-529455275
   PubMed Web of Science ®Google Scholar
• Masser DR, Hadad N, Porter H, et al. Analysis of DNA modifications in aging research. Geroscience. 2018;40(1):11–29. doi:10.1007/s11357-018-0005-329327208
   PubMed Web of Science ®Google Scholar
• Kim S, Wyckoff J, Morris AT, et al. DNA methylation associated with healthy aging of elderly twins. Geroscience. 2018;40(5–6):469–484. doi:10.1007/s11357-018-0040-030136078
   PubMed Web of Science ®Google Scholar